Evidence map›Paper›PMID 42004206›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

AI-powered analysis of affective dimensions in speech and its relevance for FTD diagnosis.

Agnès Denève, Rosalie Dauchez, Thibaud Lebouvier, Fabien D'Hondt, Maxime Bertoux

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Agnès DenèveLille Neuroscience & Cognition, Inserm U1172, Univ Lille CHU Lille France.ORCID https://orcid.org/0009-0003-9125-2763
Rosalie DauchezLille Neuroscience & Cognition, Inserm U1172, Univ Lille CHU Lille France.
Thibaud LebouvierLille Neuroscience & Cognition, Inserm U1172, Univ Lille CHU Lille France.ORCID https://orcid.org/0000-0002-4386-6045
Fabien D'HondtLille Neuroscience & Cognition, Inserm U1172, Univ Lille CHU Lille France.ORCID https://orcid.org/0000-0001-5683-0490
Maxime BertouxLille Neuroscience & Cognition, Inserm U1172, Univ Lille CHU Lille France.ORCID https://orcid.org/0000-0002-5283-503X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAffective disturbances are common across behavioral variant frontotemporal degeneration (bvFTD), primary psychiatric disorders (PPD), and Alzheimer's disease (AD). Objective markers are needed for differential and transdiagnostic characterization. We tested whether artificial intelligence (AI)-based analysis of natural speech could provide such markers.

methodsSpeech from 112 participants (bvFTD = 31, AD = 28, PPD = 15, controls = 39) was analyzed using a fine-tuned speech emotion recognition model estimating valence, arousal, dominance, and entropy. Group differences were assessed with analyses of covariance, diagnostic utility with logistic regression, and neuroanatomical correlates with voxel-based morphometry.

resultsGroup-specific affective profiles emerged. Overall, PPD exhibited a lower valence. bvFTD and AD showed a reduced arousal and a higher dominance. Affective dimensions predicted bvFTD with 80.4% accuracy (area under the curve  =  0.732) and mapped onto fronto-insular and temporal networks. Entropy was identified as a transdiagnostic marker. DISCUSSION: AI-based speech analysis provides objective, scalable biomarkers for differential diagnosis, transdiagnostic characterization, and disease monitoring.

Indexed as

affective prosodyAlzheimer's diseaseartificial intelligencebehavioral variant frontotemporal dementiaemotion recognitionneuroimagingpsychiatric disordersspeech

Identifiers

PMID42004206
PMCPMC13083222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.